OPNT Stock Overview
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.
Opiant Pharmaceuticals, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$20.12|
|52 Week High||US$37.71|
|52 Week Low||US$7.34|
|1 Month Change||107.17%|
|3 Month Change||67.81%|
|1 Year Change||-17.51%|
|3 Year Change||41.89%|
|5 Year Change||-34.87%|
|Change since IPO||-83.23%|
Recent News & Updates
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Analysts Just Slashed This Year's EstimatesAug 13
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Shares Could Be 47% Below Their Intrinsic Value EstimateAug 05
Analysts Just Made A Major Revision To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Revenue ForecastsMar 21
Opiant Pharmaceuticals (NASDAQ:OPNT) Is Posting Healthy Earnings, But It Is Not All Good NewsNov 19
These 4 Measures Indicate That Opiant Pharmaceuticals (NASDAQ:OPNT) Is Using Debt Reasonably WellNov 17
Party Time: Brokers Just Made Major Increases To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Earnings ForecastsAug 07
Increases to CEO Compensation Might Be Put On Hold For Now at Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)Jun 09
The Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Yearly Results Are Out And Analysts Have Published New ForecastsMar 06
News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) ForecastsMar 05
Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years.Jan 27
|OPNT||US Pharmaceuticals||US Market|
Return vs Industry: OPNT underperformed the US Pharmaceuticals industry which returned 12.2% over the past year.
Return vs Market: OPNT exceeded the US Market which returned -20.5% over the past year.
|OPNT Average Weekly Movement||32.4%|
|Pharmaceuticals Industry Average Movement||11.0%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: OPNT is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 32% a week.
Volatility Over Time: OPNT's weekly volatility has increased from 20% to 32% over the past year.
About the Company
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders.
Opiant Pharmaceuticals, Inc. Fundamentals Summary
|OPNT fundamental statistics|
Is OPNT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|OPNT income statement (TTM)|
|Cost of Revenue||US$29.45m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-6.40|
|Net Profit Margin||-148.12%|
How did OPNT perform over the long term?See historical performance and comparison